share_log

Maxim Group Initiates Coverage On Helius Medical Tech With Buy Rating, Announces Price Target of $1

Maxim Group Initiates Coverage On Helius Medical Tech With Buy Rating, Announces Price Target of $1

美心集團以購買評級啟動 Helius 醫療科技覆蓋範圍,宣佈目標價格為 1 美元
Benzinga Real-time News ·  2022/12/20 08:48

Maxim Group analyst Anthony Vendetti initiates coverage on Helius Medical Tech (NASDAQ:HSDT) with a Buy rating and announces Price Target of $1.

Maxim Group分析師Anthony Vendetti對Helius Medical Tech(納斯達克:HSDT)發起買入評級,並宣佈目標價為1美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論